Mechanism of Action of Topical Retinoids in Acne Treatment

Primary Comedolytic Mechanisms

• The American Academy of Dermatology recommends topical retinoids as they decrease the cohesiveness of follicular epithelial cells, preventing new microcomedone formation while resolving existing lesions in patients with acne 1

Additional Therapeutic Effects

• Topical retinoids improve post-inflammatory dyspigmentation through their effects on cellular turnover and differentiation, making them particularly valuable for patients with darker skin tones 1
• These agents enable maintenance of acne clearance after initial treatment because they continuously prevent microcomedo formation, the precursor to all acne lesions 1

Clinical Implications of Mechanism

• The broad mechanism targeting both comedone formation and inflammation justifies topical retinoids as the cornerstone and first-line treatment for most acne types 1
• The four FDA-approved topical retinoids (tretinoin, adapalene, tazarotene, and trifarotene) all share these core mechanisms but differ in receptor selectivity and tolerability 1

Common Mechanistic Pitfalls

• Tretinoin is photolabile and undergoes oxidation when combined with benzoyl peroxide, which inactivates the medication—this is why some formulations must be applied in the evening separately from benzoyl peroxide 1
• Newer formulations (tretinoin microsphere, adapalene, tazarotene) lack these chemical stability restrictions due to their molecular structure 1
• The mechanism of action causes predictable local adverse effects (erythema, dryness, peeling) during early treatment as cellular turnover accelerates, but these effects can be mitigated by reduced application frequency and concurrent moisturizer use 1